Managing Cancer And Living Meaningfully: study protocol for a randomized controlled trial

Chris Lo, Sarah Hales, Anne Rydall, Tania Panday, Aubrey Chiu, Carmine Malfitano, Judy Jung, Madeline Li, Rinat Nissim, Camilla Zimmermann, Gary Rodin, Chris Lo, Sarah Hales, Anne Rydall, Tania Panday, Aubrey Chiu, Carmine Malfitano, Judy Jung, Madeline Li, Rinat Nissim, Camilla Zimmermann, Gary Rodin

Abstract

Background: We have developed a novel and brief semi-structured psychotherapeutic intervention for patients with advanced or metastatic cancer, called Managing Cancer And Living Meaningfully. We describe here the methodology of a randomized controlled trial to test the efficacy of this treatment to alleviate distress and promote well-being in this population.

Methods/design: The study is an unblinded randomized controlled trial with 2 conditions (intervention plus usual care versus usual care alone) and assessments at baseline, 3 and 6 months. The site is the Princess Margaret Cancer Centre, part of the University Health Network, in Toronto, Canada. Eligibility criteria include: ≥ 18 years of age; English fluency; no cognitive impairment; and diagnosis of advanced cancer. The 3-6 session intervention is manualized and allows for flexibility to meet individual patients' needs. It is delivered over a 3-6 month period and provides reflective space for patients (and their primary caregivers) to address 4 main domains: symptom management and communication with health care providers; changes in self and relations with close others; sense of meaning and purpose; and the future and mortality. Usual care at the Princess Margaret Cancer Centre includes distress screening and referral as required to in-hospital psychosocial and palliative care services. The primary outcome is frequency of depressive symptoms and the primary endpoint is at 3 months. Secondary outcomes include diagnosis of major or minor depression, generalized anxiety, death anxiety, spiritual well-being, quality of life, demoralization, attachment security, posttraumatic growth, communication with partners, and satisfaction with clinical interactions.

Discussion: Managing Cancer And Living Meaningfully has the potential to relieve distress and promote psychological well-being in patients with advanced cancer and their primary caregivers. This trial is being conducted to determine its benefit and inform its dissemination. The intervention has cross-national relevance and training workshops have been held thus far with clinicians from North and South America, Europe, the Middle East, Asia and Africa.

Trial registration: ClinicalTrials.gov NCT01506492 4 January 2012.

References

    1. Lo C, Zimmermann C, Rydall AC, Walsh A, Jones JM, Moore MJ, et al. Longitudinal study of depressive symptoms in patients with metastatic gastrointestinal and lung cancer. J Clin Oncol. 2010;28(18):3084–9. doi: 10.1200/JCO.2009.26.9712.
    1. Rodin G, Lo C, Mikulincer M, Donner A, Gagliese L, Zimmermann C. Pathways to distress: the multiple determinants of depression, hopelessness and the desire for hastened death in metastatic cancer patients. Soc Sci Med. 2009;68(3):562–9. doi: 10.1016/j.socscimed.2008.10.037.
    1. Rodin G, Zimmermann C. Psychoanalytic reflections on mortality: a reconsideration. J Am Acad Psychoanal Dyn Psychiatry. 2008;36(1):181–96. doi: 10.1521/jaap.2008.36.1.181.
    1. Nissim R, Freeman E, Lo C, Zimmermann C, Gagliese L, Rydall A, et al. Managing Cancer and Living Meaningfully (CALM): a qualitative study of a brief individual psychotherapy for individuals with advanced cancer. Palliat Med. 2012;26(5):713–21. doi: 10.1177/0269216311425096.
    1. Rodin G, Walsh A, Zimmermann C, Gagliese L, Jones J, Shepherd FA, et al. The contribution of attachment security and social support to depressive symptoms in patients with metastatic cancer. Psycho-Oncology. 2007;16(12):1080–91. doi: 10.1002/pon.1186.
    1. Rodin G, Zimmermann C, Rydall A, Jones J, Shepherd FA, Moore M, et al. The desire for hastened death in patients with metastatic cancer. J Pain Symptom Manage. 2007;33(6):661–5. doi: 10.1016/j.jpainsymman.2006.09.034.
    1. Nissim R, Gagliese L, Rodin G. The desire for hastened death in individuals with advanced cancer: a longitudinal qualitative study. Soc Sci Med. 2009;69(2):165–71. doi: 10.1016/j.socscimed.2009.04.021.
    1. Luyten P, Blatt SJ, van Houdenhove BJ, Corveleyn J. Depression research and treatment: are we skating to where the puck is going to be? Clin Psychol Rev. 2006;26(8):985–99. doi: 10.1016/j.cpr.2005.12.003.
    1. Akechi T, Okuyama T, Onishi J, Morita T, Furukawa TA. Psychotherapy for depression among incurable cancer patients. Cochrane Database Syst Rev. 2008;2
    1. Edelman S, Bell DR, Kidman AD. A group cognitive behaviour therapy programme with metastatic breast cancer patients. Psycho-Oncology. 1999;8:295–305. doi: 10.1002/(SICI)1099-1611(199907/08)8:4<295::AID-PON386>;2-Y.
    1. Clark MM, Bostwick JM, Rummans TA. Group and individual treatment strategies for distress in cancer patients. Mayo Clin Proc. 2003;78(12):1538–43. doi: 10.4065/78.12.1538.
    1. Sherman AC, Pennington J, Latif U, Farley H, Arent L, Simonton S. Patient preferences regarding cancer group psychotherapy interventions: a view from the inside. Psychosomatics. 2007;48(5):426–32. doi: 10.1176/appi.psy.48.5.426.
    1. Edwards AG, Hulbert-Williams N, Neal RD. Psychological interventions for women with metastatic breast cancer. Cochrane Database Syst Rev. 2008;3
    1. Hales S, Lo C, Rodin G. Managing Cancer And Living Meaningfully (CALM) Treatment Manual: an individual psychotherapy for patients with advanced cancer. Toronto, Ontario, Canada: Princess Margaret Hospital, University Health Network; 2010.
    1. Hales S, Lo C, Rodin G. Managing Cancer And Living Meaningfully (CALM) Therapy (Chapter 62) In: Holland JC, Breitbart WS, Butow PN, Jacobsen PB, Loscalzo MJ, McCorkle R, editors. Psycho-Oncology. 3. New York: Oxford University Press; 2015. pp. 487–91.
    1. Spiegel D, Bloom JR, Yalom I. Group support for patients with metastatic cancer: a randomized outcome study. Arch Gen Psychiatry. 1981;38(5):527–33. doi: 10.1001/archpsyc.1980.01780300039004.
    1. Spiegel D, Morrow GR, Classen C, Raubertas R, Stott PB, Mudaliar N, et al. Group psychotherapy for recently diagnosed breast cancer patients: a multicenter feasibility study. Psycho-Oncology. 1999;8(6):482–93. doi: 10.1002/(SICI)1099-1611(199911/12)8:6<482::AID-PON402>;2-W.
    1. Spiegel D, Spira P. Supportive-expressive group therapy: a treatment manual of psychosocial intervention for women with recurrent breast cancer. Stanford, CA: Psychosocial Treatment Laboratory, Stanford University School of Medicine; 1991.
    1. Spiegel D, Classen C. Group therapy for cancer patients: a research-based handbook of psychosocial care. New York: Basic Books; 2000.
    1. Classen C, Butler LD, Koopman C, Miller E, DiMiceli S, Giese-Davis J, et al. Supportive-expressive group therapy and distress in patients with metastatic breast cancer: a randomized clinical intervention trial. Arch Gen Psychiatry. 2001;58(5):494–501. doi: 10.1001/archpsyc.58.5.494.
    1. Goodwin PJ, Leszcz M, Ennis M, Koopmans J, Vincent L, Guther H, et al. The effect of group psychosocial support on survival in metastatic breast cancer. N Engl J Med. 2001;345(24):1719–26. doi: 10.1056/NEJMoa011871.
    1. Giese-Davis J, Koopman C, Butler LD, Classen C, Cordova M, Fobair P, et al. Change in emotion-regulation strategy for women with metastatic breast cancer following supportive-expressive group therapy. J Consult Clin Psychol. 2002;70(4):916–25. doi: 10.1037/0022-006X.70.4.916.
    1. Bordeleau L, Szalai JP, Ennis M, Leszcz M, Speca M, Sela R, et al. Quality of life in a randomized trial of group psychosocial support in metastatic breast cancer: overall effects of the intervention and an exploration of missing data. J Clin Oncol. 2003;21(10):1944–51. doi: 10.1200/JCO.2003.04.080.
    1. Weiss JJ, Mulder CL, Antoni MH, de Vroome EM, Garssen B, Goodkin K. Effects of a supportive-expressive group intervention on long-term psychosocial adjustment in HIV-infected gay men. Psychother Psychosom. 2003;72(3):132–40. doi: 10.1159/000069732.
    1. Kissane DW, Bloch S, Smith GC, Miach P, Clarke DM, Ikin J, et al. Cognitive-existential group psychotherapy for women with primary breast cancer: a randomised controlled trial. Psychooncology. 2003;12(6):532–46. doi: 10.1002/pon.683.
    1. Kissane DW, Love A, Hatton A, Bloch S, Smith G, Clarke DM, et al. Effect of cognitive-existential group therapy on survival in early-stage breast cancer. J Clin Oncol. 2004;22(21):4255–60. doi: 10.1200/JCO.2004.12.129.
    1. Breitbart W, Gibson C, Poppito SR, Berg A. Psychotherapeutic interventions at the end of life: a focus on meaning and spirituality. Can J Psychiatry. 2004;49(6):366–72.
    1. Block SD. Perspectives on care at the close of life. Psychological considerations, growth, and transcendence at the end of life: the art of the possible. JAMA. 2001;285(22):2898–905. doi: 10.1001/jama.285.22.2898.
    1. Schwarzer R, Siebert U. Methods, procedures, and contextual characteristics of health technology assessment and health policy decision making: comparison of health technology assessment agencies in Germany, United Kingdom, France, and Sweden. Int J Technol Assess Health Care. 2009;25(3):305–14. doi: 10.1017/S0266462309990092.
    1. Zimmermann C, Seccareccia D, Clarke A, Warr D, Rodin G. Bringing palliative care to a Canadian cancer center: the palliative care program at Princess Margaret Hospital. Support Care Cancer. 2006;14(10):982–7. doi: 10.1007/s00520-006-0093-y.
    1. Katzman R, Brown T, Fuld P, Peck A, Schechter R, Schimm H. Validation of a short Orientation-Memory-Concentration Test of cognitive impairment. Am J Psychiatry. 1983;140(6):734–9. doi: 10.1176/ajp.140.6.734.
    1. Mitchell SA. Relational concepts in psychoanalysis: an integration. Cambridge, MA: Harvard University Press; 1988.
    1. Bowlby J. Attachment. New York, NY: Basic Books; 1982.
    1. Yalom ID. Existential psychotherapy. New York, NY: Basic Books; 1980.
    1. Bagha SM, Macedo A, Jacks LM, Lo C, Zimmermann C, Rodin GM, et al. The utility of the Edmonton Symptom Assessment System (ESAS) in screening for anxiety and depression. Eur J Cancer. 2013;22(1):60–9. doi: 10.1111/j.1365-2354.2012.01369.x.
    1. Ellis J, Lin J, Walsh A, Lo C, Shepherd FA, Moore M, et al. Predictors of referral for specialized psychosocial oncology care in patients with metastatic cancer: the contributions of age, distress, and marital status. J Clin Oncol. 2009;27(5):699–705. doi: 10.1200/JCO.2007.15.4864.
    1. Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–13. doi: 10.1046/j.1525-1497.2001.016009606.x.
    1. Ell K, Xie B, Quon B, Quinn DI, Dwight-Johnson M, Lee PJ. Randomized controlled trial of collaborative care management of depression among low-income patients with cancer. J Clin Oncol. 2008;26(27):4488–96. doi: 10.1200/JCO.2008.16.6371.
    1. Spitzer RL, Kroenke K, Williams JB, and the Patient Health Questionnaire Primary Care Study Group Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. JAMA. 1999;282(18):1737–44. doi: 10.1001/jama.282.18.1737.
    1. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-patient Edition. (SCID-I/NP) New York, NY: Biometrics Research, New York State Psychiatric Institute; 2010.
    1. American Psychiatric Association . Diagnostic and statistical manual of mental disorders, 4th edition, Text revision (DSM-IV-TR) Washington, DC: American Psychiatric Association Press; 2000.
    1. Spitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–7. doi: 10.1001/archinte.166.10.1092.
    1. Peterman AH, Fitchett G, Brady MJ, Hernandez L, Cella D. Measuring spiritual well-being in people with cancer: the functional assessment of chronic illness therapy -Spiritual Well-being Scale (FACIT-Sp) Ann Behav Med. 2002;24(1):49–58. doi: 10.1207/S15324796ABM2401_06.
    1. Morita T, Murata J, Kishi E, Miyashita M, Yamaguchi T, Uchitomi Y. Meaninglessness in terminally ill patients: a randomized controlled study. J Pain Symptom Manage. 2009;37(4):649–58. doi: 10.1016/j.jpainsymman.2008.04.017.
    1. Breitbart W, Rosenfeld B, Gibson C, Pessin H, Poppito S, Nelson C, et al. Meaning-centred group psychotherapy for patients with advanced cancer: a pilot randomized controlled trial. Psycho-Oncology. 2010;19(1):21–8. doi: 10.1002/pon.1556.
    1. Tedeschi RG, Calhoun LG. Trauma & transformation: growing in the aftermath of suffering. Thousand Oaks, CA: Sage Publications; 1995.
    1. Tedeschi RG, Calhoun LG. The Posttraumatic Growth Inventory: measuring the positive legacy of trauma. J Trauma Stress. 1996;9(3):455–71. doi: 10.1002/jts.2490090305.
    1. Tedeschi RG, Calhoun LG. Posttraumatic growth: conceptual foundations and empirical evidence. Psychological Inquiry. 2004;15:1–18. doi: 10.1207/s15327965pli1501_01.
    1. Stanton AL, Bower JE, Low CA. Posttraumatic growth after cancer. In: Calhoun LG, Tedeschi RG, editors. Handbook of posttraumatic growth. Mahwah, NJ: Lawrence Erlbaum; 2006. pp. 138–75.
    1. Lieberman MA, Golant M, Giese-Davis J, Winzlenberg A, Benjamin H, Humphreys K, et al. Electronic support groups for breast carcinoma: a clinical trial of effectiveness. Cancer. 2003;97(4):920–5. doi: 10.1002/cncr.11145.
    1. Wagner B, Knaevelsrud C, Maercker A. Post-traumatic growth and optimism as outcomes of an internet-based intervention for complicated grief. Cogn Behav Ther. 2007;36(3):156–61. doi: 10.1080/16506070701339713.
    1. Lo C, Burman D, Swami N, Gagliese L, Rodin G, Zimmermann C. Validation of the QUAL-EC for assessing quality of life in patients with advanced cancer. Eur J Cancer. 2011;47(4):554–60. doi: 10.1016/j.ejca.2010.10.027.
    1. Lo C, Hales S, Zimmermann C, Gagliese L, Rydall A, Rodin G. Measuring death-related anxiety in advanced cancer: preliminary psychometrics of the Death and Dying Distress Scale. J Pediatr Hematol Oncol. 2011;33(Suppl 2):S140–5. doi: 10.1097/MPH.0b013e318230e1fd.
    1. Neimeyer RA. Death anxiety handbook: research, instrumentation, and application. Washington, DC: Taylor & Francis; 1994.
    1. Kissane DW, Wein S, Love A, Lee XQ, Kee PL, Clarke DM. The Demoralization Scale: a report of its development and preliminary validation. J Palliat Care. 2004;20(4):269–76.
    1. Lo C, Walsh A, Mikulincer M, Gagliese L, Zimmermann C, Rodin G. Measuring attachment security in patients with advanced cancer: psychometric properties of a modified and brief Experiences in Close Relationships scale. Psycho-Oncology. 2009;18(5):490–9. doi: 10.1002/pon.1417.
    1. Olson DH, Larson PJ. PREPARE/ENRICH: Customized Version. Minneapolis, MN: Life Innovations; 2008.
    1. Karnofsky D, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: Macleod CM, editor. Evaluation of chemotherapeutic agents. New York, NY: Columbia University; 1949. pp. 191–205.
    1. Portenoy RK, Thaler HT, Kornblith AB, Lepore JM, Friedlander-Klar H, Kiyasu E, et al. The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer. 1994;30A(9):1326–36. doi: 10.1016/0959-8049(94)90182-1.
    1. Borm GF, Fransen J, Lemmens WAJG. A simple sample size formula for analysis of covariance in randomized clinical trials. J Clin Epidemiol. 2007;60(12):1234–8. doi: 10.1016/j.jclinepi.2007.02.006.
    1. Cohen J. Statistical power analyses for the behavioral sciences. 2. Hillsdale, NJ: Lawrence Erlbaum; 1988.
    1. Strong V, Waters R, Hibberd C, Murray G, Wall L, McHugh G, et al. Management of depression for people with cancer (SMaRT oncology 1): a randomised trial. Lancet. 2008;372(9632):40–8. doi: 10.1016/S0140-6736(08)60991-5.
    1. Lachin JM. Introduction to sample size determination and power analysis for clinical trials. Control Clin Trials. 1981;2(2):93–113. doi: 10.1016/0197-2456(81)90001-5.
    1. Meinert CL. Clinical trials: design, conduct and analysis. USA: Oxford University Press; 1986.
    1. Lo C, Hales S, Jung J, Chiu A, Panday T, Rydall A, et al. Managing Cancer And Living Meaningfully (CALM): phase 2 trial of a brief individual psychotherapy for patients with metastatic cancer. Palliat Med. 2014;28(3):234–42. doi: 10.1177/0269216313507757.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe